Change in Breast Cancer Screening Participation during COVID-19 Based on the 2019 and 2022 Comprehensive Survey of Living Conditions in Japan.

IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL
JMA journal Pub Date : 2025-01-15 Epub Date: 2024-12-20 DOI:10.31662/jmaj.2024-0234
Chitose Kawamura, Masao Iwagami, Jun Komiyama, Yuta Taniguchi, Yu Sun, Rie Masuda, Takehiro Sugiyama, Hiroko Bando, Tomomi Kihara, Hiroyasu Iso, Nanako Tamiya
{"title":"Change in Breast Cancer Screening Participation during COVID-19 Based on the 2019 and 2022 Comprehensive Survey of Living Conditions in Japan.","authors":"Chitose Kawamura, Masao Iwagami, Jun Komiyama, Yuta Taniguchi, Yu Sun, Rie Masuda, Takehiro Sugiyama, Hiroko Bando, Tomomi Kihara, Hiroyasu Iso, Nanako Tamiya","doi":"10.31662/jmaj.2024-0234","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The breast cancer screening rate declined worldwide during the COVID-19 pandemic. This cross-sectional study examined the changes in breast cancer screening participation rates in Japan before and during the pandemic and identified subgroups with a larger decline.</p><p><strong>Methods: </strong>We used data from a 2019 survey evaluating 2017-2018 (pre-pandemic) and a 2022 survey evaluating 2020-2021 (during the pandemic) in the Comprehensive Survey of Living Conditions to describe the breast cancer screening rates by screening settings among women aged 40-74 years. We calculated the changes in the overall participation rate and by subgroup with and without adjustment for other variables (i.e., age, living area, educational level, and health insurance).</p><p><strong>Results: </strong>The participation rates in breast cancer screening in 2017-2018 and 2020-2021 were 48.3% (51,428/106,446, municipality-based 18.7%, worksite-based 17.0%, and others 12.6%) and 47.1% (45,006/95,610, municipality-based 17.2%, worksite-based 17.5%, and others 12.4%), respectively. The crude difference from 2017-2018 to 2020-2021 was -1.2% (95% confidence interval [CI], -1.7 to -0.8), and the adjusted difference was -1.7% (-2.2 to -1.4). By subgroup, the adjusted difference was the largest in the 45-49 age subgroup (-2.2% [-3.3 to -1.1]) among the age subgroups, in the town/village subgroup (-2.4% [-3.6 to -1.2]) among the living area subgroups, in the high school subgroup (-1.8% [-2.4 to -1.2]) and vocational school/junior or technical college subgroup (-1.8% [-2.6 to -1.0]) among the educational level subgroups, and in the employee insurance (dependent person) subgroup (-2.5% [-3.3 to -1.7]) among the health insurance subgroups.</p><p><strong>Conclusions: </strong>The breast cancer screening participation rates decreased during the pandemic in Japan, with some variations by subgroup. For the screening setting, the participation rate of the municipality-based screening decreased, while that of the worksite-based screening increased.</p>","PeriodicalId":73550,"journal":{"name":"JMA journal","volume":"8 1","pages":"183-190"},"PeriodicalIF":1.5000,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799596/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMA journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31662/jmaj.2024-0234","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/20 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The breast cancer screening rate declined worldwide during the COVID-19 pandemic. This cross-sectional study examined the changes in breast cancer screening participation rates in Japan before and during the pandemic and identified subgroups with a larger decline.

Methods: We used data from a 2019 survey evaluating 2017-2018 (pre-pandemic) and a 2022 survey evaluating 2020-2021 (during the pandemic) in the Comprehensive Survey of Living Conditions to describe the breast cancer screening rates by screening settings among women aged 40-74 years. We calculated the changes in the overall participation rate and by subgroup with and without adjustment for other variables (i.e., age, living area, educational level, and health insurance).

Results: The participation rates in breast cancer screening in 2017-2018 and 2020-2021 were 48.3% (51,428/106,446, municipality-based 18.7%, worksite-based 17.0%, and others 12.6%) and 47.1% (45,006/95,610, municipality-based 17.2%, worksite-based 17.5%, and others 12.4%), respectively. The crude difference from 2017-2018 to 2020-2021 was -1.2% (95% confidence interval [CI], -1.7 to -0.8), and the adjusted difference was -1.7% (-2.2 to -1.4). By subgroup, the adjusted difference was the largest in the 45-49 age subgroup (-2.2% [-3.3 to -1.1]) among the age subgroups, in the town/village subgroup (-2.4% [-3.6 to -1.2]) among the living area subgroups, in the high school subgroup (-1.8% [-2.4 to -1.2]) and vocational school/junior or technical college subgroup (-1.8% [-2.6 to -1.0]) among the educational level subgroups, and in the employee insurance (dependent person) subgroup (-2.5% [-3.3 to -1.7]) among the health insurance subgroups.

Conclusions: The breast cancer screening participation rates decreased during the pandemic in Japan, with some variations by subgroup. For the screening setting, the participation rate of the municipality-based screening decreased, while that of the worksite-based screening increased.

基于2019年和2022年日本生活状况综合调查的COVID-19期间乳腺癌筛查参与情况的变化
导言:在2019冠状病毒病大流行期间,全球乳腺癌筛查率下降。这项横断面研究调查了日本在大流行之前和期间乳腺癌筛查参与率的变化,并确定了下降幅度较大的亚组。方法:我们使用生活条件综合调查中2019年评估2017-2018年(大流行前)的调查数据和2022年评估2020-2021年(大流行期间)的调查数据,描述40-74岁女性中筛查设置的乳腺癌筛查率。我们计算了总体参与率的变化,并按亚组计算了其他变量(即年龄、居住面积、教育水平和医疗保险)的调整情况。结果:2017-2018年和2020-2021年乳腺癌筛查参与率分别为48.3%(51,428/106,446,城市为18.7%,工作场所为17.0%,其他12.6%)和47.1%(45,006/95,610,城市为17.2%,工作场所为17.5%,其他12.4%)。2017-2018年与2020-2021年的粗差为-1.2%(95%置信区间[CI], -1.7至-0.8),调整后的差为-1.7%(-2.2至-1.4)。按亚组划分,调整后的差异在45-49岁亚组中最大(-2.2%[-3.3至-1.1]),在居住区域亚组中最大(-2.4%[-3.6至-1.2]),在高中亚组中最大(-1.8%[-2.4至-1.2]),在教育水平亚组中最大(-1.8%[-2.6至-1.0])。在雇员保险(受抚养人)子组中,在健康保险子组中(-2.5%[-3.3至-1.7])。结论:大流行期间,乳腺癌筛查参与率在日本有所下降,亚组之间存在一些差异。对于筛查设置,以市政为基础的筛查参与率下降,而以工作场所为基础的筛查参与率上升。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信